IMPORTANCE of PRETREATMENT 18F-FDG PET/CT TEXTURE ANALYSIS in PREDICTING EGFR and ALK MUTATION in PATIENTS with NON-SMALL CELL LUNG CANCER

被引:10
作者
Aguloglu, Nursin [1 ]
Aksu, Aysegul [1 ]
Akyol, Murat [1 ]
Katgi, Nuran [1 ]
Doksoz, Tugce Ciftci [1 ]
机构
[1] Bahcesehir Cam & Sakura Hastanesi, Istanbul, Turkey
来源
NUKLEARMEDIZIN-NUCLEAR MEDICINE | 2022年 / 61卷 / 06期
关键词
18F-FDG-PET; CT; Lung cancer; Textural analysis; EGFR; ALK; IMAGING PHENOTYPES; SOMATIC MUTATIONS; ADENOCARCINOMA;
D O I
10.1055/a-1868-4918
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective Identification of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR) mutation types is of great importance before treatment with tyrosine kinase inhibitors (TKIs). Radiomics is a new strategy for noninvasively predicting the genetic status of cancer. We aimed to evaluate the predictive power of 18F-FDG PET/CT-based radiomic features for mutational status before treatment in non-small cell lung cancer (NSCLC) and to develop a predictive model based on radiomic features. Methods Images of patients who underwent 18F-FDG PET/CT for initial staging with the diagnosis of NSCLC between January 2015 and July 2020 were evaluated using LIFEx software. The region of interest (ROI) of the primary tumor was established and volumetric and textural features were obtained. Clinical data and radiomic data were evaluated with machine learning (ML) algorithms to create a model. Results For EGFR mutation prediction, the most successful machine learning algorithm obtained with GLZLM_GLNU and clinical data was Naive Bayes (AUC: 0.751, MCC: 0.347, acc: 71.4%). For ALK rearrangement prediction, the most successful machine learning algorithm obtained with GLCM_correlation, GLZLM_LZHGE and clinical data was evaluated as Naive Bayes (AUC: 0.682, MCC: 0.221, acc: 77.4%). Conclusions In our study, we created prediction models based on radiomic analysis of 18F-FDG PET/CT images. Tissue analysis with ML algorithms are non-invasive methods for predicting ALK rearrangement and EGFR mutation status in NSCLC, which may be useful for targeted therapy selection in a clinical setting.
引用
收藏
页码:433 / 439
页数:7
相关论文
共 50 条
[41]   Comparison of 18F-FLT PET and 18F-FDG PET for preoperative staging in non-small cell lung cancer [J].
Yamamoto, Yuka ;
Nishiyama, Yoshihiro ;
Kimura, Naruhide ;
Ishikawa, Shinya ;
Okuda, Masaya ;
Bandoh, Shuji ;
Kanaji, Nobuhiro ;
Asakura, Masato ;
Ohkawa, Motoomi .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (02) :236-245
[42]   Comparison of 18F-FLT PET and 18F-FDG PET for preoperative staging in non-small cell lung cancer [J].
Yuka Yamamoto ;
Yoshihiro Nishiyama ;
Naruhide Kimura ;
Shinya Ishikawa ;
Masaya Okuda ;
Shuji Bandoh ;
Nobuhiro Kanaji ;
Masato Asakura ;
Motoomi Ohkawa .
European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 :236-245
[43]   18F-FDG uptake and EGFR mutations in patients with non-small cell lung cancer: A single-institution retrospective analysis [J].
Na, Im Il ;
Byun, Byung Hyun ;
Kim, Kyeong Min ;
Cheon, Gi Jeong ;
Choe, Du Hwan ;
Koh, Jae Soo ;
Lee, Duck Yong ;
Ryoo, Baek-Yeol ;
Baek, HeeJong ;
Lim, Sang Moo ;
Yang, Sung Hyun ;
Kim, Cheol Hyeon ;
Lee, Jae Cheol .
LUNG CANCER, 2010, 67 (01) :76-80
[44]   The diagnostic and predictive efficacy of 18F-FDG PET/CT metabolic parameters for EGFR mutation status in non-small-cell lung cancer: A meta-analysis [J].
Guo, Yue ;
Zhu, Hui ;
Yao, Zhiming ;
Liu, Fugeng ;
Yang, Dawei .
EUROPEAN JOURNAL OF RADIOLOGY, 2021, 141
[45]   Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer [J].
Cho, Arthur ;
Hur, Jin ;
Moon, Yong Wha ;
Hong, Sae Rom ;
Suh, Young Joo ;
Kim, Yun Jung ;
Im, Dong Jin ;
Hong, Yoo Jin ;
Lee, Hye-Jeong ;
Kim, Young Jin ;
Shim, Hyo Sup ;
Lee, Jae Seok ;
Kim, Joo-Hang ;
Choi, Byoung Wook .
BMC CANCER, 2016, 16
[46]   MUTATION ANALYSIS OF THE EGFR GENE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IN XINJIANG [J].
Shi, Yi ;
Pang, Xue-Lian ;
Ma, Zhi-Ping ;
Cui, Wen-Li ;
Zhang, Wei ;
Ma, Yu-Qing .
ACTA MEDICA MEDITERRANEA, 2021, 37 (06) :3363-3368
[47]   Diagnostic value of dynamic 18F-FDG PET/CT imaging in non-small cell lung cancer and FDG hypermetabolic lymph nodes [J].
Sun, Yishan ;
Xiao, Liming ;
Wang, Yanmei ;
Liu, Changping ;
Cao, Li ;
Zhai, Wei ;
Wang, Bo ;
Yu, Shupeng ;
Xin, Jun .
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2023, 13 (04) :2556-2567
[48]   Is Delayed Image of 18F-FDG PET/CT Necessary for Mediastinal Lymph Node Staging in Non-Small Cell Lung Cancer Patients? [J].
Lee, Sang Woo ;
Kim, Seong-Jang .
CLINICAL NUCLEAR MEDICINE, 2022, 47 (05) :414-421
[49]   Elevated Metabolic Activity on 18F-FDG PET/CT Is Associated with the Expression of EZH2 in Non-small Cell Lung Cancer [J].
Toyokawa, Gouji ;
Takada, Kazuki ;
Okamoto, Tatsuro ;
Kozuma, Yuka ;
Matsubara, Taichi ;
Haratake, Naoki ;
Akamine, Takaki ;
Takamori, Shinkichi ;
Katsura, Masakazu ;
Shoji, Fumihiro ;
Hamamoto, Ryuji ;
Oda, Yoshinao ;
Maehara, Yoshihiko .
ANTICANCER RESEARCH, 2017, 37 (03) :1393-1401
[50]   Impact of 18F-FDG PET/CT in Staging Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis [J].
Martucci, Francesco ;
Pascale, Mariarosa ;
Valli, Maria Carla ;
Pesce, Gianfranco A. ;
Froesch, Patrizia ;
Giovanella, Luca ;
Richetti, Antonella ;
Treglia, Giorgio .
FRONTIERS IN MEDICINE, 2020, 6